サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1263547

世界のパクスロビド API市場：考察と予測 (2029年まで)

Global Paxlovid API Market Insights, Forecast to 2029
出版日: | 発行: QYResearch | ページ情報: 英文 88 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
世界のパクスロビド API市場：考察と予測 (2029年まで)
出版日: 2023年04月25日
発行: QYResearch
ページ情報: 英文 88 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、パクスロビド API (Paxlovid API) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • パクスロビド APIの製品概要
  • 市場：タイプ別
    • 世界のパクスロビド API 市場規模：タイプ別, 2018 VS 2022 VS 2029
    • Purity ≥99%
    • Purity ≥99.5%
  • 市場：用途別
    • 世界のパクスロビド API 市場規模：用途別, 2018 VS 2022 VS 2029
    • COVID-19 Oral Drugs
    • Research Reagents
    • Other
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 世界のパクスロビド APIの生産

  • 世界のパクスロビド APIの生産能力 (2018-2029)
  • 世界のパクスロビド APIの生産 地域別: 2018 VS 2022 VS 2029
  • 世界のパクスロビド APIの生産 地域別
    • 世界のパクスロビド APIの生産実績：地域別 (2018-2023)
    • 世界のパクスロビド APIの生産予測：地域別 (2024-2029)
    • 世界のパクスロビド APIの生産 市場 シェア 地域別 (2018-2029)
  • 北米
  • 欧州
  • 中国
  • インド

第3章 レポート概要

  • 世界のパクスロビド APIの収益 推定および予測 2018-2029
  • 世界のパクスロビド APIの収益：地域別
    • 世界のパクスロビド APIの収益：地域別: 2018 VS 2022 VS 2029
    • 世界のパクスロビド APIの収益：地域別 (2018-2023)
    • 世界のパクスロビド APIの収益：地域別 (2024-2029)
    • 世界のパクスロビド APIの収益市場シェア 地域別 (2018-2029)
  • 世界のパクスロビド API売上予測・予想 2018-2029
  • 世界のパクスロビド APIの販売：地域別
    • 世界のパクスロビド APIの販売：地域別: 2018 VS 2022 VS 2029
    • 世界のパクスロビド APIの販売：地域別 (2018-2023)
    • 世界のパクスロビド APIの販売：地域別 (2024-2029)
    • 世界のパクスロビド APIの販売市場シェア 地域別 (2018-2029)
  • US & カナダ
  • 欧州
  • 中国
  • アジア（中国を除く）
  • 中東, アフリカ ・ラテンアメリカ

第4章 競合：企業別

  • 世界のパクスロビド APIの販売：企業別
    • 世界のパクスロビド APIの販売：企業別 (2018-2023)
    • 世界のパクスロビド APIの販売市場シェア：企業別 (2018-2023)
    • 世界の上位10・上位5企業： パクスロビド API2022
  • 世界のパクスロビド APIの収益：企業別
    • 世界のパクスロビド APIの収益：企業別 (2018-2023)
    • 世界のパクスロビド APIの収益市場シェア：企業別 (2018-2023)
    • 世界の上位10・上位5企業： パクスロビド APIの収益 2022
  • 世界のパクスロビド APIの販売価格：企業別
  • 世界の主要企業 パクスロビド API, 業界ランキング, 2021 VS 2022 VS 2023
  • 競合情勢の分析
    • 企業の市場集中度 (CR5 and HHI)
    • 世界のパクスロビド APIの市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要メーカー パクスロビド API, 製造拠点分布と本社
  • 世界の主要メーカー パクスロビド API, 提供製品と用途
  • 世界の主要メーカー パクスロビド API, 業界参入時期
  • M&A, 拡張計画

第5章 市場規模：タイプ別

  • 世界のパクスロビド APIの販売：タイプ別
    • 世界のパクスロビド APIの販売実績：タイプ別 (2018-2023)
    • 世界のパクスロビド APIの販売予測：タイプ別 (2024-2029)
    • 世界のパクスロビド APIの販売市場シェア：タイプ別 (2018-2029)
  • 世界のパクスロビド API 収益：タイプ別
    • 世界のパクスロビド APIの収益実績：タイプ別 (2018-2023)
    • 世界のパクスロビド APIの収益予測：タイプ別 (2024-2029)
    • 世界のパクスロビド APIの収益市場シェア：タイプ別 (2018-2029)
  • 世界のパクスロビド APIの価格：タイプ別
    • 世界のパクスロビド APIの価格：タイプ別 (2018-2023)
    • 世界のパクスロビド APIの価格予測：タイプ別 (2024-2029)

第6章 市場規模：用途別

  • 世界のパクスロビド APIの販売：用途別
    • 世界のパクスロビド APIの販売実績：用途別 (2018-2023)
    • 世界のパクスロビド APIの販売予測：用途別 (2024-2029)
    • 世界のパクスロビド APIの販売市場シェア：用途別 (2018-2029)
  • 世界のパクスロビド APIの収益：用途別
    • 世界のパクスロビド APIの収益実績：用途別 (2018-2023)
    • 世界のパクスロビド APIの収益予測：用途別 (2024-2029)
    • 世界のパクスロビド APIの収益市場シェア：用途別 (2018-2029)
  • 世界のパクスロビド APIの価格：用途別
    • 世界のパクスロビド APIの価格：用途別 (2018-2023)
    • 世界のパクスロビド APIの価格予測：用途別 (2024-2029)

第7章 US & カナダ

  • US & カナダ パクスロビド API 市場規模：タイプ別
    • US & カナダ パクスロビド APIの販売：タイプ別 (2018-2029)
    • US & カナダ パクスロビド API 収益：タイプ別 (2018-2029)
  • US & カナダ パクスロビド API 市場規模：用途別
    • US & カナダ パクスロビド APIの販売：用途別 (2018-2029)
    • US & カナダ パクスロビド APIの収益：用途別 (2018-2029)
  • US & カナダ パクスロビド APIの販売：国別
    • US & カナダ パクスロビド APIの収益：国別: 2018 VS 2022 VS 2029
    • US & カナダ パクスロビド APIの販売：国別 (2018-2029)
    • US & カナダ パクスロビド APIの収益：国別 (2018-2029)
    • 米国
    • カナダ

第8章 欧州

  • 欧州のパクスロビド API 市場規模：タイプ別
    • 欧州のパクスロビド APIの販売：タイプ別 (2018-2029)
    • 欧州のパクスロビド API 収益：タイプ別 (2018-2029)
  • 欧州のパクスロビド API 市場規模：用途別
    • 欧州のパクスロビド APIの販売：用途別 (2018-2029)
    • 欧州のパクスロビド APIの収益：用途別 (2018-2029)
  • 欧州のパクスロビド APIの販売：国別
    • 欧州のパクスロビド APIの収益：国別: 2018 VS 2022 VS 2029
    • 欧州のパクスロビド APIの販売：国別 (2018-2029)
    • 欧州のパクスロビド APIの収益：国別 (2018-2029)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第9章 中国

  • 中国のパクスロビド API 市場規模：タイプ別
    • 中国のパクスロビド APIの販売：タイプ別 (2018-2029)
    • 中国のパクスロビド API 収益：タイプ別 (2018-2029)
  • 中国のパクスロビド API 市場規模：用途別
    • 中国のパクスロビド APIの販売：用途別 (2018-2029)
    • 中国のパクスロビド APIの収益：用途別 (2018-2029)

第10章 アジア（中国を除く）

  • アジア地域 パクスロビド API 市場規模：タイプ別
    • アジア地域 パクスロビド APIの販売：タイプ別 (2018-2029)
    • アジア地域 パクスロビド API 収益：タイプ別 (2018-2029)
  • アジア地域 パクスロビド API 市場規模：用途別
    • アジア地域 パクスロビド APIの販売：用途別 (2018-2029)
    • アジア地域 パクスロビド APIの収益：用途別 (2018-2029)
  • アジア地域 パクスロビド APIの販売：地域別
    • アジア地域 パクスロビド APIの収益：地域別: 2018 VS 2022 VS 2029
    • アジア地域 パクスロビド APIの収益：地域別 (2018-2029)
    • アジア地域 パクスロビド APIの販売：地域別 (2018-2029)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド

第11章 中東, アフリカ ・ラテンアメリカ

  • 中東, アフリカ ・ラテンアメリカのパクスロビド API 市場規模：タイプ別
    • 中東, アフリカ ・ラテンアメリカのパクスロビド APIの販売：タイプ別 (2018-2029)
    • 中東, アフリカ ・ラテンアメリカのパクスロビド API 収益：タイプ別 (2018-2029)
  • 中東, アフリカ ・ラテンアメリカのパクスロビド API 市場規模：用途別
    • 中東, アフリカ ・ラテンアメリカのパクスロビド APIの販売：用途別 (2018-2029)
    • 中東, アフリカ ・ラテンアメリカのパクスロビド APIの収益：用途別 (2018-2029)
  • 中東, アフリカ ・ラテンアメリカのパクスロビド APIの販売：国別
    • 中東, アフリカ ・ラテンアメリカのパクスロビド APIの収益：国別: 2018 VS 2022 VS 2029
    • 中東, アフリカ ・ラテンアメリカのパクスロビド APIの収益：国別 (2018-2029)
    • 中東, アフリカ ・ラテンアメリカのパクスロビド APIの販売：国別 (2018-2029)
    • ブラジル
    • メキシコ
    • トルコ
    • イスラエル
    • 湾岸協力理事会諸国

第12章 企業プロファイル

  • Pfizer
  • Nanjing Hicin Pharmaceutical
  • Lepu Medical
  • HAS Biotech
  • Novasep

第13章 業界チェーンと販売チャネルの分析

  • パクスロビド API 業界チェーン分析
  • パクスロビド API 主要原材料
    • 主要原材料
    • 原材料の主要サプライヤー
  • パクスロビド API 生産形態とプロセス
  • パクスロビド API 販売およびマーケティング
    • パクスロビド API 販売チャネル
    • パクスロビド API 卸業者
  • パクスロビド API 顧客

第14章 パクスロビド API 市場動向

  • パクスロビド API 業界動向
  • パクスロビド API 市場の促進要因
  • パクスロビド API 市場の課題
  • パクスロビド API 市場の抑制要因

第15章 世界のパクスロビド APIの主な市場調査結果

第16章 付録

図表

List of Tables

  • Table 1. Global Paxlovid API Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 2. Major Manufacturers of Purity ≥99%
  • Table 3. Major Manufacturers of Purity ≥99.5%
  • Table 4. Global Paxlovid API Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 5. Global Paxlovid API Production by Region: 2018 VS 2022 VS 2029 (Tons)
  • Table 6. Global Paxlovid API Production by Region (2018-2023) & (Tons)
  • Table 7. Global Paxlovid API Production by Region (2024-2029) & (Tons)
  • Table 8. Global Paxlovid API Production Market Share by Region (2018-2023)
  • Table 9. Global Paxlovid API Production Market Share by Region (2024-2029)
  • Table 10. Global Paxlovid API Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 11. Global Paxlovid API Revenue by Region (2018-2023) & (US$ Million)
  • Table 12. Global Paxlovid API Revenue by Region (2024-2029) & (US$ Million)
  • Table 13. Global Paxlovid API Revenue Market Share by Region (2018-2023)
  • Table 14. Global Paxlovid API Revenue Market Share by Region (2024-2029)
  • Table 15. Global Paxlovid API Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 16. Global Paxlovid API Sales by Region (2018-2023) & (Tons)
  • Table 17. Global Paxlovid API Sales by Region (2024-2029) & (Tons)
  • Table 18. Global Paxlovid API Sales Market Share by Region (2018-2023)
  • Table 19. Global Paxlovid API Sales Market Share by Region (2024-2029)
  • Table 20. Global Paxlovid API Sales by Manufacturers (2018-2023) & (Tons)
  • Table 21. Global Paxlovid API Sales Share by Manufacturers (2018-2023)
  • Table 22. Global Paxlovid API Revenue by Manufacturers (2018-2023) & (US$ Million)
  • Table 23. Global Paxlovid API Revenue Share by Manufacturers (2018-2023)
  • Table 24. Paxlovid API Price by Manufacturers 2018-2023 (US$/Ton)
  • Table 25. Global Key Players of Paxlovid API, Industry Ranking, 2021 VS 2022 VS 2023
  • Table 26. Global Paxlovid API Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 27. Global Paxlovid API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paxlovid API as of 2022)
  • Table 28. Global Key Manufacturers of Paxlovid API, Manufacturing Base Distribution and Headquarters
  • Table 29. Global Key Manufacturers of Paxlovid API, Product Offered and Application
  • Table 30. Global Key Manufacturers of Paxlovid API, Date of Enter into This Industry
  • Table 31. Mergers & Acquisitions, Expansion Plans
  • Table 32. Global Paxlovid API Sales by Type (2018-2023) & (Tons)
  • Table 33. Global Paxlovid API Sales by Type (2024-2029) & (Tons)
  • Table 34. Global Paxlovid API Sales Share by Type (2018-2023)
  • Table 35. Global Paxlovid API Sales Share by Type (2024-2029)
  • Table 36. Global Paxlovid API Revenue by Type (2018-2023) & (US$ Million)
  • Table 37. Global Paxlovid API Revenue by Type (2024-2029) & (US$ Million)
  • Table 38. Global Paxlovid API Revenue Share by Type (2018-2023)
  • Table 39. Global Paxlovid API Revenue Share by Type (2024-2029)
  • Table 40. Paxlovid API Price by Type (2018-2023) & (US$/Ton)
  • Table 41. Global Paxlovid API Price Forecast by Type (2024-2029) & (US$/Ton)
  • Table 42. Global Paxlovid API Sales by Application (2018-2023) & (Tons)
  • Table 43. Global Paxlovid API Sales by Application (2024-2029) & (Tons)
  • Table 44. Global Paxlovid API Sales Share by Application (2018-2023)
  • Table 45. Global Paxlovid API Sales Share by Application (2024-2029)
  • Table 46. Global Paxlovid API Revenue by Application (2018-2023) & (US$ Million)
  • Table 47. Global Paxlovid API Revenue by Application (2024-2029) & (US$ Million)
  • Table 48. Global Paxlovid API Revenue Share by Application (2018-2023)
  • Table 49. Global Paxlovid API Revenue Share by Application (2024-2029)
  • Table 50. Paxlovid API Price by Application (2018-2023) & (US$/Ton)
  • Table 51. Global Paxlovid API Price Forecast by Application (2024-2029) & (US$/Ton)
  • Table 52. US & Canada Paxlovid API Sales by Type (2018-2023) & (Tons)
  • Table 53. US & Canada Paxlovid API Sales by Type (2024-2029) & (Tons)
  • Table 54. US & Canada Paxlovid API Revenue by Type (2018-2023) & (US$ Million)
  • Table 55. US & Canada Paxlovid API Revenue by Type (2024-2029) & (US$ Million)
  • Table 56. US & Canada Paxlovid API Sales by Application (2018-2023) & (Tons)
  • Table 57. US & Canada Paxlovid API Sales by Application (2024-2029) & (Tons)
  • Table 58. US & Canada Paxlovid API Revenue by Application (2018-2023) & (US$ Million)
  • Table 59. US & Canada Paxlovid API Revenue by Application (2024-2029) & (US$ Million)
  • Table 60. US & Canada Paxlovid API Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 61. US & Canada Paxlovid API Revenue by Country (2018-2023) & (US$ Million)
  • Table 62. US & Canada Paxlovid API Revenue by Country (2024-2029) & (US$ Million)
  • Table 63. US & Canada Paxlovid API Sales by Country (2018-2023) & (Tons)
  • Table 64. US & Canada Paxlovid API Sales by Country (2024-2029) & (Tons)
  • Table 65. Europe Paxlovid API Sales by Type (2018-2023) & (Tons)
  • Table 66. Europe Paxlovid API Sales by Type (2024-2029) & (Tons)
  • Table 67. Europe Paxlovid API Revenue by Type (2018-2023) & (US$ Million)
  • Table 68. Europe Paxlovid API Revenue by Type (2024-2029) & (US$ Million)
  • Table 69. Europe Paxlovid API Sales by Application (2018-2023) & (Tons)
  • Table 70. Europe Paxlovid API Sales by Application (2024-2029) & (Tons)
  • Table 71. Europe Paxlovid API Revenue by Application (2018-2023) & (US$ Million)
  • Table 72. Europe Paxlovid API Revenue by Application (2024-2029) & (US$ Million)
  • Table 73. Europe Paxlovid API Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 74. Europe Paxlovid API Revenue by Country (2018-2023) & (US$ Million)
  • Table 75. Europe Paxlovid API Revenue by Country (2024-2029) & (US$ Million)
  • Table 76. Europe Paxlovid API Sales by Country (2018-2023) & (Tons)
  • Table 77. Europe Paxlovid API Sales by Country (2024-2029) & (Tons)
  • Table 78. China Paxlovid API Sales by Type (2018-2023) & (Tons)
  • Table 79. China Paxlovid API Sales by Type (2024-2029) & (Tons)
  • Table 80. China Paxlovid API Revenue by Type (2018-2023) & (US$ Million)
  • Table 81. China Paxlovid API Revenue by Type (2024-2029) & (US$ Million)
  • Table 82. China Paxlovid API Sales by Application (2018-2023) & (Tons)
  • Table 83. China Paxlovid API Sales by Application (2024-2029) & (Tons)
  • Table 84. China Paxlovid API Revenue by Application (2018-2023) & (US$ Million)
  • Table 85. China Paxlovid API Revenue by Application (2024-2029) & (US$ Million)
  • Table 86. Asia Paxlovid API Sales by Type (2018-2023) & (Tons)
  • Table 87. Asia Paxlovid API Sales by Type (2024-2029) & (Tons)
  • Table 88. Asia Paxlovid API Revenue by Type (2018-2023) & (US$ Million)
  • Table 89. Asia Paxlovid API Revenue by Type (2024-2029) & (US$ Million)
  • Table 90. Asia Paxlovid API Sales by Application (2018-2023) & (Tons)
  • Table 91. Asia Paxlovid API Sales by Application (2024-2029) & (Tons)
  • Table 92. Asia Paxlovid API Revenue by Application (2018-2023) & (US$ Million)
  • Table 93. Asia Paxlovid API Revenue by Application (2024-2029) & (US$ Million)
  • Table 94. Asia Paxlovid API Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 95. Asia Paxlovid API Revenue by Region (2018-2023) & (US$ Million)
  • Table 96. Asia Paxlovid API Revenue by Region (2024-2029) & (US$ Million)
  • Table 97. Asia Paxlovid API Sales by Region (2018-2023) & (Tons)
  • Table 98. Asia Paxlovid API Sales by Region (2024-2029) & (Tons)
  • Table 99. Middle East, Africa and Latin America Paxlovid API Sales by Type (2018-2023) & (Tons)
  • Table 100. Middle East, Africa and Latin America Paxlovid API Sales by Type (2024-2029) & (Tons)
  • Table 101. Middle East, Africa and Latin America Paxlovid API Revenue by Type (2018-2023) & (US$ Million)
  • Table 102. Middle East, Africa and Latin America Paxlovid API Revenue by Type (2024-2029) & (US$ Million)
  • Table 103. Middle East, Africa and Latin America Paxlovid API Sales by Application (2018-2023) & (Tons)
  • Table 104. Middle East, Africa and Latin America Paxlovid API Sales by Application (2024-2029) & (Tons)
  • Table 105. Middle East, Africa and Latin America Paxlovid API Revenue by Application (2018-2023) & (US$ Million)
  • Table 106. Middle East, Africa and Latin America Paxlovid API Revenue by Application (2024-2029) & (US$ Million)
  • Table 107. Middle East, Africa and Latin America Paxlovid API Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 108. Middle East, Africa and Latin America Paxlovid API Revenue by Country (2018-2023) & (US$ Million)
  • Table 109. Middle East, Africa and Latin America Paxlovid API Revenue by Country (2024-2029) & (US$ Million)
  • Table 110. Middle East, Africa and Latin America Paxlovid API Sales by Country (2018-2023) & (Tons)
  • Table 111. Middle East, Africa and Latin America Paxlovid API Sales by Country (2024-2029) & (Tons)
  • Table 112. Pfizer Company Information
  • Table 113. Pfizer Description and Major Businesses
  • Table 114. Pfizer Paxlovid API Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
  • Table 115. Pfizer Paxlovid API Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 116. Pfizer Recent Development
  • Table 117. Nanjing Hicin Pharmaceutical Company Information
  • Table 118. Nanjing Hicin Pharmaceutical Description and Major Businesses
  • Table 119. Nanjing Hicin Pharmaceutical Paxlovid API Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
  • Table 120. Nanjing Hicin Pharmaceutical Paxlovid API Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 121. Nanjing Hicin Pharmaceutical Recent Development
  • Table 122. Lepu Medical Company Information
  • Table 123. Lepu Medical Description and Major Businesses
  • Table 124. Lepu Medical Paxlovid API Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
  • Table 125. Lepu Medical Paxlovid API Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 126. Lepu Medical Recent Development
  • Table 127. HAS Biotech Company Information
  • Table 128. HAS Biotech Description and Major Businesses
  • Table 129. HAS Biotech Paxlovid API Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
  • Table 130. HAS Biotech Paxlovid API Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 131. HAS Biotech Recent Development
  • Table 132. Novasep Company Information
  • Table 133. Novasep Description and Major Businesses
  • Table 134. Novasep Paxlovid API Capacity Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2023)
  • Table 135. Novasep Paxlovid API Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 136. Novasep Recent Development
  • Table 137. Key Raw Materials Lists
  • Table 138. Raw Materials Key Suppliers Lists
  • Table 139. Paxlovid API Distributors List
  • Table 140. Paxlovid API Customers List
  • Table 141. Paxlovid API Market Trends
  • Table 142. Paxlovid API Market Drivers
  • Table 143. Paxlovid API Market Challenges
  • Table 144. Paxlovid API Market Restraints
  • Table 145. Research Programs/Design for This Report
  • Table 146. Key Data Information from Secondary Sources
  • Table 147. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Paxlovid API Product Picture
  • Figure 2. Global Paxlovid API Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 3. Global Paxlovid API Market Share by Type in 2022 & 2029
  • Figure 4. Purity ≥99% Product Picture
  • Figure 5. Purity ≥99.5% Product Picture
  • Figure 6. Global Paxlovid API Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 7. Global Paxlovid API Market Share by Application in 2022 & 2029
  • Figure 8. COVID-19 Oral Drugs
  • Figure 9. Research Reagents
  • Figure 10. Other
  • Figure 11. Paxlovid API Report Years Considered
  • Figure 12. Global Paxlovid API Capacity, Production and Utilization (2018-2029) & (Tons)
  • Figure 13. Global Paxlovid API Production Market Share by Region in Percentage: 2022 Versus 2029
  • Figure 14. Global Paxlovid API Production Market Share by Region (2018-2029)
  • Figure 15. Paxlovid API Production Growth Rate in North America (2018-2029) & (Tons)
  • Figure 16. Paxlovid API Production Growth Rate in Europe (2018-2029) & (Tons)
  • Figure 17. Paxlovid API Production Growth Rate in China (2018-2029) & (Tons)
  • Figure 18. Paxlovid API Production Growth Rate in India (2018-2029) & (Tons)
  • Figure 19. Global Paxlovid API Revenue, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 20. Global Paxlovid API Revenue 2018-2029 (US$ Million)
  • Figure 21. Global Paxlovid API Revenue (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 22. Global Paxlovid API Revenue Market Share by Region in Percentage: 2022 Versus 2029
  • Figure 23. Global Paxlovid API Revenue Market Share by Region (2018-2029)
  • Figure 24. Global Paxlovid API Sales 2018-2029 ((Tons)
  • Figure 25. Global Paxlovid API Sales (CAGR) by Region: 2018 VS 2022 VS 2029 (Tons)
  • Figure 26. Global Paxlovid API Sales Market Share by Region (2018-2029)
  • Figure 27. US & Canada Paxlovid API Sales YoY (2018-2029) & (Tons)
  • Figure 28. US & Canada Paxlovid API Revenue YoY (2018-2029) & (US$ Million)
  • Figure 29. Europe Paxlovid API Sales YoY (2018-2029) & (Tons)
  • Figure 30. Europe Paxlovid API Revenue YoY (2018-2029) & (US$ Million)
  • Figure 31. China Paxlovid API Sales YoY (2018-2029) & (Tons)
  • Figure 32. China Paxlovid API Revenue YoY (2018-2029) & (US$ Million)
  • Figure 33. Asia (excluding China) Paxlovid API Sales YoY (2018-2029) & (Tons)
  • Figure 34. Asia (excluding China) Paxlovid API Revenue YoY (2018-2029) & (US$ Million)
  • Figure 35. Middle East, Africa and Latin America Paxlovid API Sales YoY (2018-2029) & (Tons)
  • Figure 36. Middle East, Africa and Latin America Paxlovid API Revenue YoY (2018-2029) & (US$ Million)
  • Figure 37. The Paxlovid API Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
  • Figure 38. The Top 5 and 10 Largest Manufacturers of Paxlovid API in the World: Market Share by Paxlovid API Revenue in 2022
  • Figure 39. Global Paxlovid API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
  • Figure 40. Global Paxlovid API Sales Market Share by Type (2018-2029)
  • Figure 41. Global Paxlovid API Revenue Market Share by Type (2018-2029)
  • Figure 42. Global Paxlovid API Sales Market Share by Application (2018-2029)
  • Figure 43. Global Paxlovid API Revenue Market Share by Application (2018-2029)
  • Figure 44. US & Canada Paxlovid API Sales Market Share by Type (2018-2029)
  • Figure 45. US & Canada Paxlovid API Revenue Market Share by Type (2018-2029)
  • Figure 46. US & Canada Paxlovid API Sales Market Share by Application (2018-2029)
  • Figure 47. US & Canada Paxlovid API Revenue Market Share by Application (2018-2029)
  • Figure 48. US & Canada Paxlovid API Revenue Share by Country (2018-2029)
  • Figure 49. US & Canada Paxlovid API Sales Share by Country (2018-2029)
  • Figure 50. U.S. Paxlovid API Revenue (2018-2029) & (US$ Million)
  • Figure 51. Canada Paxlovid API Revenue (2018-2029) & (US$ Million)
  • Figure 52. Europe Paxlovid API Sales Market Share by Type (2018-2029)
  • Figure 53. Europe Paxlovid API Revenue Market Share by Type (2018-2029)
  • Figure 54. Europe Paxlovid API Sales Market Share by Application (2018-2029)
  • Figure 55. Europe Paxlovid API Revenue Market Share by Application (2018-2029)
  • Figure 56. Europe Paxlovid API Revenue Share by Country (2018-2029)
  • Figure 57. Europe Paxlovid API Sales Share by Country (2018-2029)
  • Figure 58. Germany Paxlovid API Revenue (2018-2029) & (US$ Million)
  • Figure 59. France Paxlovid API Revenue (2018-2029) & (US$ Million)
  • Figure 60. U.K. Paxlovid API Revenue (2018-2029) & (US$ Million)
  • Figure 61. Italy Paxlovid API Revenue (2018-2029) & (US$ Million)
  • Figure 62. Russia Paxlovid API Revenue (2018-2029) & (US$ Million)
  • Figure 63. China Paxlovid API Sales Market Share by Type (2018-2029)
  • Figure 64. China Paxlovid API Revenue Market Share by Type (2018-2029)
  • Figure 65. China Paxlovid API Sales Market Share by Application (2018-2029)
  • Figure 66. China Paxlovid API Revenue Market Share by Application (2018-2029)
  • Figure 67. Asia Paxlovid API Sales Market Share by Type (2018-2029)
  • Figure 68. Asia Paxlovid API Revenue Market Share by Type (2018-2029)
  • Figure 69. Asia Paxlovid API Sales Market Share by Application (2018-2029)
  • Figure 70. Asia Paxlovid API Revenue Market Share by Application (2018-2029)
  • Figure 71. Asia Paxlovid API Revenue Share by Region (2018-2029)
  • Figure 72. Asia Paxlovid API Sales Share by Region (2018-2029)
  • Figure 73. Japan Paxlovid API Revenue (2018-2029) & (US$ Million)
  • Figure 74. South Korea Paxlovid API Revenue (2018-2029) & (US$ Million)
  • Figure 75. China Taiwan Paxlovid API Revenue (2018-2029) & (US$ Million)
  • Figure 76. Southeast Asia Paxlovid API Revenue (2018-2029) & (US$ Million)
  • Figure 77. India Paxlovid API Revenue (2018-2029) & (US$ Million)
  • Figure 78. Middle East, Africa and Latin America Paxlovid API Sales Market Share by Type (2018-2029)
  • Figure 79. Middle East, Africa and Latin America Paxlovid API Revenue Market Share by Type (2018-2029)
  • Figure 80. Middle East, Africa and Latin America Paxlovid API Sales Market Share by Application (2018-2029)
  • Figure 81. Middle East, Africa and Latin America Paxlovid API Revenue Market Share by Application (2018-2029)
  • Figure 82. Middle East, Africa and Latin America Paxlovid API Revenue Share by Country (2018-2029)
  • Figure 83. Middle East, Africa and Latin America Paxlovid API Sales Share by Country (2018-2029)
  • Figure 84. Brazil Paxlovid API Revenue (2018-2029) & (US$ Million)
  • Figure 85. Mexico Paxlovid API Revenue (2018-2029) & (US$ Million)
  • Figure 86. Turkey Paxlovid API Revenue (2018-2029) & (US$ Million)
  • Figure 87. Israel Paxlovid API Revenue (2018-2029) & (US$ Million)
  • Figure 88. GCC Countries Paxlovid API Revenue (2018-2029) & (US$ Million)
  • Figure 89. Paxlovid API Value Chain
  • Figure 90. Paxlovid API Production Process
  • Figure 91. Channels of Distribution
  • Figure 92. Distributors Profiles
  • Figure 93. Bottom-up and Top-down Approaches for This Report
  • Figure 94. Data Triangulation
  • Figure 95. Key Executives Interviewed
目次

This research report focuses on the Paxlovid API Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Paxlovid API Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Paxlovid API Market Size by Type, 2018 VS 2022 VS 2029
    • 1.2.2 Purity ≥99%
    • 1.2.3 Purity ≥99.5%
  • 1.3 Market by Application
    • 1.3.1 Global Paxlovid API Market Size by Application, 2018 VS 2022 VS 2029
    • 1.3.2 COVID-19 Oral Drugs
    • 1.3.3 Research Reagents
    • 1.3.4 Other
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Paxlovid API Production

  • 2.1 Global Paxlovid API Production Capacity (2018-2029)
  • 2.2 Global Paxlovid API Production by Region: 2018 VS 2022 VS 2029
  • 2.3 Global Paxlovid API Production by Region
    • 2.3.1 Global Paxlovid API Historic Production by Region (2018-2023)
    • 2.3.2 Global Paxlovid API Forecasted Production by Region (2024-2029)
    • 2.3.3 Global Paxlovid API Production Market Share by Region (2018-2029)
  • 2.4 North America
  • 2.5 Europe
  • 2.6 China
  • 2.7 India

3 Executive Summary

  • 3.1 Global Paxlovid API Revenue Estimates and Forecasts 2018-2029
  • 3.2 Global Paxlovid API Revenue by Region
    • 3.2.1 Global Paxlovid API Revenue by Region: 2018 VS 2022 VS 2029
    • 3.2.2 Global Paxlovid API Revenue by Region (2018-2023)
    • 3.2.3 Global Paxlovid API Revenue by Region (2024-2029)
    • 3.2.4 Global Paxlovid API Revenue Market Share by Region (2018-2029)
  • 3.3 Global Paxlovid API Sales Estimates and Forecasts 2018-2029
  • 3.4 Global Paxlovid API Sales by Region
    • 3.4.1 Global Paxlovid API Sales by Region: 2018 VS 2022 VS 2029
    • 3.4.2 Global Paxlovid API Sales by Region (2018-2023)
    • 3.4.3 Global Paxlovid API Sales by Region (2024-2029)
    • 3.4.4 Global Paxlovid API Sales Market Share by Region (2018-2029)
  • 3.5 US & Canada
  • 3.6 Europe
  • 3.7 China
  • 3.8 Asia (excluding China)
  • 3.9 Middle East, Africa and Latin America

4 Competition by Manufactures

  • 4.1 Global Paxlovid API Sales by Manufacturers
    • 4.1.1 Global Paxlovid API Sales by Manufacturers (2018-2023)
    • 4.1.2 Global Paxlovid API Sales Market Share by Manufacturers (2018-2023)
    • 4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Paxlovid API in 2022
  • 4.2 Global Paxlovid API Revenue by Manufacturers
    • 4.2.1 Global Paxlovid API Revenue by Manufacturers (2018-2023)
    • 4.2.2 Global Paxlovid API Revenue Market Share by Manufacturers (2018-2023)
    • 4.2.3 Global Top 10 and Top 5 Companies by Paxlovid API Revenue in 2022
  • 4.3 Global Paxlovid API Sales Price by Manufacturers
  • 4.4 Global Key Players of Paxlovid API, Industry Ranking, 2021 VS 2022 VS 2023
  • 4.5 Analysis of Competitive Landscape
    • 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 4.5.2 Global Paxlovid API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 4.6 Global Key Manufacturers of Paxlovid API, Manufacturing Base Distribution and Headquarters
  • 4.7 Global Key Manufacturers of Paxlovid API, Product Offered and Application
  • 4.8 Global Key Manufacturers of Paxlovid API, Date of Enter into This Industry
  • 4.9 Mergers & Acquisitions, Expansion Plans

5 Market Size by Type

  • 5.1 Global Paxlovid API Sales by Type
    • 5.1.1 Global Paxlovid API Historical Sales by Type (2018-2023)
    • 5.1.2 Global Paxlovid API Forecasted Sales by Type (2024-2029)
    • 5.1.3 Global Paxlovid API Sales Market Share by Type (2018-2029)
  • 5.2 Global Paxlovid API Revenue by Type
    • 5.2.1 Global Paxlovid API Historical Revenue by Type (2018-2023)
    • 5.2.2 Global Paxlovid API Forecasted Revenue by Type (2024-2029)
    • 5.2.3 Global Paxlovid API Revenue Market Share by Type (2018-2029)
  • 5.3 Global Paxlovid API Price by Type
    • 5.3.1 Global Paxlovid API Price by Type (2018-2023)
    • 5.3.2 Global Paxlovid API Price Forecast by Type (2024-2029)

6 Market Size by Application

  • 6.1 Global Paxlovid API Sales by Application
    • 6.1.1 Global Paxlovid API Historical Sales by Application (2018-2023)
    • 6.1.2 Global Paxlovid API Forecasted Sales by Application (2024-2029)
    • 6.1.3 Global Paxlovid API Sales Market Share by Application (2018-2029)
  • 6.2 Global Paxlovid API Revenue by Application
    • 6.2.1 Global Paxlovid API Historical Revenue by Application (2018-2023)
    • 6.2.2 Global Paxlovid API Forecasted Revenue by Application (2024-2029)
    • 6.2.3 Global Paxlovid API Revenue Market Share by Application (2018-2029)
  • 6.3 Global Paxlovid API Price by Application
    • 6.3.1 Global Paxlovid API Price by Application (2018-2023)
    • 6.3.2 Global Paxlovid API Price Forecast by Application (2024-2029)

7 US & Canada

  • 7.1 US & Canada Paxlovid API Market Size by Type
    • 7.1.1 US & Canada Paxlovid API Sales by Type (2018-2029)
    • 7.1.2 US & Canada Paxlovid API Revenue by Type (2018-2029)
  • 7.2 US & Canada Paxlovid API Market Size by Application
    • 7.2.1 US & Canada Paxlovid API Sales by Application (2018-2029)
    • 7.2.2 US & Canada Paxlovid API Revenue by Application (2018-2029)
  • 7.3 US & Canada Paxlovid API Sales by Country
    • 7.3.1 US & Canada Paxlovid API Revenue by Country: 2018 VS 2022 VS 2029
    • 7.3.2 US & Canada Paxlovid API Sales by Country (2018-2029)
    • 7.3.3 US & Canada Paxlovid API Revenue by Country (2018-2029)
    • 7.3.4 U.S.
    • 7.3.5 Canada

8 Europe

  • 8.1 Europe Paxlovid API Market Size by Type
    • 8.1.1 Europe Paxlovid API Sales by Type (2018-2029)
    • 8.1.2 Europe Paxlovid API Revenue by Type (2018-2029)
  • 8.2 Europe Paxlovid API Market Size by Application
    • 8.2.1 Europe Paxlovid API Sales by Application (2018-2029)
    • 8.2.2 Europe Paxlovid API Revenue by Application (2018-2029)
  • 8.3 Europe Paxlovid API Sales by Country
    • 8.3.1 Europe Paxlovid API Revenue by Country: 2018 VS 2022 VS 2029
    • 8.3.2 Europe Paxlovid API Sales by Country (2018-2029)
    • 8.3.3 Europe Paxlovid API Revenue by Country (2018-2029)
    • 8.3.4 Germany
    • 8.3.5 France
    • 8.3.6 U.K.
    • 8.3.7 Italy
    • 8.3.8 Russia

9 China

  • 9.1 China Paxlovid API Market Size by Type
    • 9.1.1 China Paxlovid API Sales by Type (2018-2029)
    • 9.1.2 China Paxlovid API Revenue by Type (2018-2029)
  • 9.2 China Paxlovid API Market Size by Application
    • 9.2.1 China Paxlovid API Sales by Application (2018-2029)
    • 9.2.2 China Paxlovid API Revenue by Application (2018-2029)

10 Asia (excluding China)

  • 10.1 Asia Paxlovid API Market Size by Type
    • 10.1.1 Asia Paxlovid API Sales by Type (2018-2029)
    • 10.1.2 Asia Paxlovid API Revenue by Type (2018-2029)
  • 10.2 Asia Paxlovid API Market Size by Application
    • 10.2.1 Asia Paxlovid API Sales by Application (2018-2029)
    • 10.2.2 Asia Paxlovid API Revenue by Application (2018-2029)
  • 10.3 Asia Paxlovid API Sales by Region
    • 10.3.1 Asia Paxlovid API Revenue by Region: 2018 VS 2022 VS 2029
    • 10.3.2 Asia Paxlovid API Revenue by Region (2018-2029)
    • 10.3.3 Asia Paxlovid API Sales by Region (2018-2029)
    • 10.3.4 Japan
    • 10.3.5 South Korea
    • 10.3.6 China Taiwan
    • 10.3.7 Southeast Asia
    • 10.3.8 India

11 Middle East, Africa and Latin America

  • 11.1 Middle East, Africa and Latin America Paxlovid API Market Size by Type
    • 11.1.1 Middle East, Africa and Latin America Paxlovid API Sales by Type (2018-2029)
    • 11.1.2 Middle East, Africa and Latin America Paxlovid API Revenue by Type (2018-2029)
  • 11.2 Middle East, Africa and Latin America Paxlovid API Market Size by Application
    • 11.2.1 Middle East, Africa and Latin America Paxlovid API Sales by Application (2018-2029)
    • 11.2.2 Middle East, Africa and Latin America Paxlovid API Revenue by Application (2018-2029)
  • 11.3 Middle East, Africa and Latin America Paxlovid API Sales by Country
    • 11.3.1 Middle East, Africa and Latin America Paxlovid API Revenue by Country: 2018 VS 2022 VS 2029
    • 11.3.2 Middle East, Africa and Latin America Paxlovid API Revenue by Country (2018-2029)
    • 11.3.3 Middle East, Africa and Latin America Paxlovid API Sales by Country (2018-2029)
    • 11.3.4 Brazil
    • 11.3.5 Mexico
    • 11.3.6 Turkey
    • 11.3.7 Israel
    • 11.3.8 GCC Countries

12 Corporate Profiles

  • 12.1 Pfizer
    • 12.1.1 Pfizer Company Information
    • 12.1.2 Pfizer Overview
    • 12.1.3 Pfizer Paxlovid API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
    • 12.1.4 Pfizer Paxlovid API Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.1.5 Pfizer Recent Developments
  • 12.2 Nanjing Hicin Pharmaceutical
    • 12.2.1 Nanjing Hicin Pharmaceutical Company Information
    • 12.2.2 Nanjing Hicin Pharmaceutical Overview
    • 12.2.3 Nanjing Hicin Pharmaceutical Paxlovid API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
    • 12.2.4 Nanjing Hicin Pharmaceutical Paxlovid API Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.2.5 Nanjing Hicin Pharmaceutical Recent Developments
  • 12.3 Lepu Medical
    • 12.3.1 Lepu Medical Company Information
    • 12.3.2 Lepu Medical Overview
    • 12.3.3 Lepu Medical Paxlovid API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
    • 12.3.4 Lepu Medical Paxlovid API Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.3.5 Lepu Medical Recent Developments
  • 12.4 HAS Biotech
    • 12.4.1 HAS Biotech Company Information
    • 12.4.2 HAS Biotech Overview
    • 12.4.3 HAS Biotech Paxlovid API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
    • 12.4.4 HAS Biotech Paxlovid API Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.4.5 HAS Biotech Recent Developments
  • 12.5 Novasep
    • 12.5.1 Novasep Company Information
    • 12.5.2 Novasep Overview
    • 12.5.3 Novasep Paxlovid API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
    • 12.5.4 Novasep Paxlovid API Product Model Numbers, Pictures, Descriptions and Specifications
    • 12.5.5 Novasep Recent Developments

13 Industry Chain and Sales Channels Analysis

  • 13.1 Paxlovid API Industry Chain Analysis
  • 13.2 Paxlovid API Key Raw Materials
    • 13.2.1 Key Raw Materials
    • 13.2.2 Raw Materials Key Suppliers
  • 13.3 Paxlovid API Production Mode & Process
  • 13.4 Paxlovid API Sales and Marketing
    • 13.4.1 Paxlovid API Sales Channels
    • 13.4.2 Paxlovid API Distributors
  • 13.5 Paxlovid API Customers

14 Paxlovid API Market Dynamics

  • 14.1 Paxlovid API Industry Trends
  • 14.2 Paxlovid API Market Drivers
  • 14.3 Paxlovid API Market Challenges
  • 14.4 Paxlovid API Market Restraints

15 Key Finding in The Global Paxlovid API Study

16 Appendix

  • 16.1 Research Methodology
    • 16.1.1 Methodology/Research Approach
    • 16.1.2 Data Source
  • 16.2 Author Details
  • 16.3 Disclaimer